Study of the Nutraceutical Properties and Health Benefits of Traditional Components of the Mediterranean Diet

NCT ID: NCT01890070

Last Updated: 2015-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The present protocol is designed to conduct nutrigenomic and nutrigenetic studies on foods conforming to the Mediterranean diet, in order to determine the effect functional foods have on blood parameters (cholesterol metabolism, glucose metabolism, hepatic function, inflammation, nutritional status) and body composition in the context of four different diets (standard, high fat, high protein, low carbohydrate). The study focuses on the effect of these nutraceutical foods in relation to different diets. Diets were chosen to reflect the standard reference diets used by the general population, so as the outcomes of the addition of each interventional food element may be interpreted in the context of a variety of dietary patterns.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study envisages the enrollment of subjects, to be recruited consecutively from May 2013 to May 2015 from the staff of the laboratory of the Evaluation of Nutritional State, Nutrigenetics and nutrigenomics of the Human Nutrition and Diet section of the University of Rome Tor Vergata.

The study will be conducted in accordance with the Declaration of Helsinki, and approved by the Committee of the Ministero delle Politiche Alimentari e Forestali (MIPAAF) , Italy, approved by DM 06/12/2011 n° prot. 32064. All participants will be required to provide written informed consent for the study.

At the time of recruitment, relevant subject data will be collected including clinical history, dietary habits, pharmacological therapy, smoking habit, alcohol consumption and level of physical activity.

Exclusion criteria include history of coronary vascular disease, peripheral or cerebro- vascular disease, hepatic disease, diagnosis of diabetes mellitus, autoimmune disease, immunodeficiency syndrome or malignant neoplasia.

The subjects enrolled will undergo:

* Anthropometric measures (body weight, height, waist, hip, abdominal, neck, arm and forearm circumferences).
* Skin fold measurements (bicipital, tricipital, subscapular, pectoral, supra iliac, abdominal, anterior thigh, internal thigh, supra patellar and popliteal);
* Blood Pressure;
* Body composition evaluation (bone, fat and lean mass), evaluated by DEXA (iDXA; GE
* Medical Systems, Milwaukee, WI) (Dual energy X-ray Absorptiometry; DPX Lunar Radiation Corp., Madison, Wisconsin, USA);
* Distribution of body fluids, evaluated by bioimpedensometry. Resistance, reactance, phase angle at 50 kHz will be measured using the Bioelectrical Impedance Analysis method (BIA 101S, by Akern/RIL System-Florence
* Analysis of genetic expression Participants will be randomized into groups.

Each group will cycle through different interventions, according to a cross over study. The interventions are represented by different dietary plans based on different meals, consisting of:

1. Standard Diet (SD) alone, and SD with functional food (40g of hazelnuts or 150 ml of biological red wine, or 100g of chestnuts, or 200g of wild mixed greens, or 100 g of olive oil, or 100 g of chocolate);
2. High Fat diet (HF) alone, and HF with functional food (40g of hazelnuts or 150 ml of biological red wine, or 100g of chestnuts, or 200g of wild mixed greens, or 100 g of olive oil, or 100 g of chocolate).
3. Low Carbohydrate diet (LC) alone, and LC with functional food (40g of hazelnuts or 150 ml of biological red wine, or 100g of chestnuts, or 200g of wild mixed greens, or 100 g of olive oil, or 100 g of chocolate).
4. High Protein (HP) alone, and HP with functional food (40g of hazelnuts or 150 ml of biological red wine, or 100g of chestnuts, or 200g of wild mixed greens, or 100 g of olive oil, or 100 g of chocolate).

The duration of the experimental period is 4 weeks for each diet, with a wash-out period of 3 weeks at the beginning of the study between one diet and the next.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

mediterranean diet, nutrigenomics, body composition, inflammation, oxidative stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

STANDARD DIET

each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Standard diet (Mediterrean reference: carbohydrates 55%-60%; protein 15% - 20% of which 50% are of vegetable derivation; total fats \< 30% e 30 g of fiber)

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type PLACEBO_COMPARATOR

No Dietary Supplement

Intervention Type OTHER

Mediterranean Reference Diet, High Fat Diet, Low Carbohydrate or High Protein Diet without an added dietary supplement (hazelnut, chocolate, red wine, wild mixed greens, chestnuts, olive oil)

STANDARD DIET WITH HAZELNUTS

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Standard diet (Mediterrean reference: carbohydrates 55%-60%; protein 15% - 20% of which 50% are of vegetable derivation; total fats \< 30% e 30 g of fibers) with 40g Italian hazelnuts from Piedmont with Protected Geographical Indication Certification

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Hazelnuts

Intervention Type DIETARY_SUPPLEMENT

Italian hazelnuts from Piedmont with Protected Geographical Indication Certification

STANDARD DIET WITH RED WINE

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day :

Standard diet (Mediterrean reference: carbohydrates 55%-60%; protein 15% - 20% of which 50% are of vegetable derivation; total fats \< 30% e 30 g of fibers) with 200 ml of Italian organic Red Wine.

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Red wine

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Red Wine

STANDARD DIET WITH CHESTNUTS

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Standard diet (Mediterrean reference: carbohydrates 55%-60%; protein 15% - 20% of which 50% are of vegetable derivation; total fats \< 30% e 30 g of fibers) with 100 g of Italian organic chestnuts.

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Chestnut

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Chestnut

STANDARD DIET WITH CHOCOLATE

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day :

Standard diet (Mediterrean reference: carbohydrates 55%-60%; protein 15% - 20% of which 50% are of vegetable derivation; total fats \< 30% e 30 g of fibers) with 100 g of Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Chocolate

Intervention Type DIETARY_SUPPLEMENT

Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

STANDARD DIET WITH WILD MIXED GREEN

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Standard diet (Mediterrean reference: carbohydrates 55%-60%; protein 15% - 20% of which 50% are of vegetable derivation; total fats \< 30% e 30 g of fibers) with 200 g of Italian organic wild mixed green

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Wild mixed greens

Intervention Type DIETARY_SUPPLEMENT

Italian organic wild mixed greens

STANDARD DIET WITH OLIVE OIL

Intervention type: each patient is administered a food plan for four weeks. Every patient patient is required to consume per day :

Standard diet (Mediterrean reference: carbohydrates 55%-60%; protein 15% - 20% of which 50% are of vegetable derivation; total fats \< 30% e 30 g of fibers) with 100g of Italian organic Olive Oil

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Olive Oil

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Olive Oil

HIGH FAT DIET

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High fat diet (carbohydrates 35%; protein 15%; total fats 50%)

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type PLACEBO_COMPARATOR

No Dietary Supplement

Intervention Type OTHER

Mediterranean Reference Diet, High Fat Diet, Low Carbohydrate or High Protein Diet without an added dietary supplement (hazelnut, chocolate, red wine, wild mixed greens, chestnuts, olive oil)

HIGH FAT WITH HAZELNUTS

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High fat diet (carbohydrates 35%; protein 15%; total fats 50%) with 40g of Italian hazelnuts from Piedmont with Protected Geographical Indication Certification.

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Hazelnuts

Intervention Type DIETARY_SUPPLEMENT

Italian hazelnuts from Piedmont with Protected Geographical Indication Certification

HIGH FAT WITH RED WINE

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High fat diet (carbohydrates 35%; protein 15%; total fats 50%)with 200 ml of Italian organic Red Wine

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Red wine

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Red Wine

HIGH FAT WITH CHESTNUT

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High fat diet (carbohydrates 35%; protein 15%; total fats 50%) with 100 g of Italian organic chestnuts.

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Chestnut

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Chestnut

HIGH FAT WITH CHOCOLATE

Intervention type: each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High fat diet (carbohydrates 35%; protein 15%; total fats 50%) with 100 g of Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Chocolate

Intervention Type DIETARY_SUPPLEMENT

Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

HIGH FAT WITH WILD MIXED GREEN

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High fat diet (carbohydrates 35%; protein 15%; total fats 50%) with 200 g of Italian organic wild mixed green

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Wild mixed greens

Intervention Type DIETARY_SUPPLEMENT

Italian organic wild mixed greens

HIGH FAT WITH OLIVE OIL

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High fat diet (carbohydrates 35%; protein 15%; total fats 50%) with 100 of Italian organic Olive oil

Three weeks of washout to avoid additive effects on treatment following.

Group Type EXPERIMENTAL

Olive Oil

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Olive Oil

LOW CARBOHYDRATE DIET

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Low carbohydrate diet (carbohydrates 35%; protein 30%; total fats 35%)

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type PLACEBO_COMPARATOR

No Dietary Supplement

Intervention Type OTHER

Mediterranean Reference Diet, High Fat Diet, Low Carbohydrate or High Protein Diet without an added dietary supplement (hazelnut, chocolate, red wine, wild mixed greens, chestnuts, olive oil)

LOW CARBOHYDRATE DIET WITH HAZELNUT

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Low carbohydrate diet (carbohydrates 35%; protein 30%; total fats 35%) with 40g Italian hazelnuts from Piedmont with Protected Geographical Indication Certification

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Hazelnuts

Intervention Type DIETARY_SUPPLEMENT

Italian hazelnuts from Piedmont with Protected Geographical Indication Certification

LOW CARBOHYDRATE DIET WITH RED WINE

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Low carbohydrate diet (carbohydrates 35%; protein 30%; total fats 35%) with 200 ml of Italian organic Red Wine

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Red wine

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Red Wine

LOW CARBOHYDRATE DIET WITH CHESTNUT

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Low carbohydrate diet (carbohydrates 35%; protein 30%; total fats 35%) with 100 g of Italian organic chestnuts

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Chestnut

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Chestnut

LOW CARBOHYDRATE DIET CHOCOLATE

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Low carbohydrate diet (carbohydrates 35%; protein 30%; total fats 35%) with 100 g of Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Chocolate

Intervention Type DIETARY_SUPPLEMENT

Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

LOW CARBOHYDRATE DIET WITH WILD MIXED GREEN

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Low carbohydrate diet (carbohydrates 35%; protein 30%; total fats 35%) with 200 g of Italian organic wild mixed green

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Wild mixed greens

Intervention Type DIETARY_SUPPLEMENT

Italian organic wild mixed greens

LOW CARBOHYDRATE DIET WITH OLIVE OIL

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

Low carbohydrate diet (carbohydrates 35%; protein 30%; total fats 35%) with 100 of Italian organic Olive Oil

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Olive Oil

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Olive Oil

HIGH PROTEIN DIET

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High protein diet (carbohydrates 30%; protein 40%; total fats 30%)

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type PLACEBO_COMPARATOR

No Dietary Supplement

Intervention Type OTHER

Mediterranean Reference Diet, High Fat Diet, Low Carbohydrate or High Protein Diet without an added dietary supplement (hazelnut, chocolate, red wine, wild mixed greens, chestnuts, olive oil)

HIGH PROTEIN DIET WITH HAZELNUT

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High protein diet (carbohydrates 30%; protein 40%; total fats 30%) with 40g Italian hazelnuts from Piedmont with Protected Geographical Indication Certification

Group Type EXPERIMENTAL

Hazelnuts

Intervention Type DIETARY_SUPPLEMENT

Italian hazelnuts from Piedmont with Protected Geographical Indication Certification

HIGH PROTEIN DIET WITH RED WINE

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High protein diet (carbohydrates 30%; protein 40%; total fats 30%) with 200 ml of Italian organic Red Wine

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Red wine

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Red Wine

HIGH PROTEIN DIET WITH CHESTNUT

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High protein diet (carbohydrates 30%; protein 40%; total fats 30%) with 100 g of Italian organic chestnuts

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Chestnut

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Chestnut

HIGH PROTEIN DIET WITH CHOCOLATE

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High protein diet (carbohydrates 30%; protein 40%; total fats 30%) with 100 g of Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Chocolate

Intervention Type DIETARY_SUPPLEMENT

Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

HIGH PROTEIN DIET WITH ITALIAN ORGANIC WILD MIXED GREEN

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High protein diet (carbohydrates 30%; protein 40%; total fats 30%) with 200 g of Italian organic wild mixed green

Three weeks of washout to avoid additive effects on treatments to follow.

Group Type EXPERIMENTAL

Wild mixed greens

Intervention Type DIETARY_SUPPLEMENT

Italian organic wild mixed greens

HIGH PROTEIN DIET WITH OLIVE OIL

Intervention type: Each patient is administered a food plan for four weeks. Every patient is required to consume per day:

High protein diet (carbohydrates 30%; protein 40%; total fats 30%) with 100 of Italian organic Olive Oil

This is followed by a 3 week wash out period, to neutralize any additive effects.

Group Type EXPERIMENTAL

Olive Oil

Intervention Type DIETARY_SUPPLEMENT

Italian Organic Olive Oil

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hazelnuts

Italian hazelnuts from Piedmont with Protected Geographical Indication Certification

Intervention Type DIETARY_SUPPLEMENT

Chocolate

Extra-dark Italian Chocolate (min. 70% of organic cocoa solids)

Intervention Type DIETARY_SUPPLEMENT

Red wine

Italian Organic Red Wine

Intervention Type DIETARY_SUPPLEMENT

Olive Oil

Italian Organic Olive Oil

Intervention Type DIETARY_SUPPLEMENT

Wild mixed greens

Italian organic wild mixed greens

Intervention Type DIETARY_SUPPLEMENT

Chestnut

Italian Organic Chestnut

Intervention Type DIETARY_SUPPLEMENT

No Dietary Supplement

Mediterranean Reference Diet, High Fat Diet, Low Carbohydrate or High Protein Diet without an added dietary supplement (hazelnut, chocolate, red wine, wild mixed greens, chestnuts, olive oil)

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Corylus avellana Theobroma cacao Vitis vinifera Olea europea Chicory, rocket, nettle Castanea sativa

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

18 to 75 years inclusive BMI \>19 kg/m2

\-

Exclusion Criteria

* Past history of ischaemic coronary artery disease
* Peripheral or cerebral vasculopathy
* Hepatic disease
* Diabetes Mellitus
* Autoimmune disease
* HIV/AIDS
* Neoplastic disease
* Use of the following medications: lipid-lowering medications, oral anti-diabetic medication or insulin, nitroglycerin, corticosteroids.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Rome Tor Vergata

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

LAURA DI RENZO

Professor of Human Nutrition

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Nutrition and Nutrigenomic, School of Medicine University of Rome Torvergata

Rome, Rome, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Laura Di Renzo, PhD

Role: CONTACT

Phone: +39 0672596855

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Di Renzo L, Gualtieri P, Frank G, Cianci R, Raffaelli G, Peluso D, Bigioni G, De Lorenzo A. Sex-Specific Adherence to the Mediterranean Diet in Obese Individuals. Nutrients. 2024 Sep 12;16(18):3076. doi: 10.3390/nu16183076.

Reference Type DERIVED
PMID: 39339676 (View on PubMed)

Gualtieri P, Marchetti M, Frank G, Smeriglio A, Trombetta D, Colica C, Cianci R, De Lorenzo A, Di Renzo L. Antioxidant-Enriched Diet on Oxidative Stress and Inflammation Gene Expression: A Randomized Controlled Trial. Genes (Basel). 2023 Jan 13;14(1):206. doi: 10.3390/genes14010206.

Reference Type DERIVED
PMID: 36672947 (View on PubMed)

Marchetti M, Gualtieri P, De Lorenzo A, Trombetta D, Smeriglio A, Ingegneri M, Cianci R, Frank G, Schifano G, Bigioni G, Di Renzo L. Dietary omega-3 intake for the treatment of morning headache: A randomized controlled trial. Front Neurol. 2022 Sep 20;13:987958. doi: 10.3389/fneur.2022.987958. eCollection 2022.

Reference Type DERIVED
PMID: 36203988 (View on PubMed)

Perrone MA, Gualtieri P, Gratteri S, Ali W, Sergi D, Muscoli S, Cammarano A, Bernardini S, Di Renzo L, Romeo F. Effects of postprandial hydroxytyrosol and derivates on oxidation of LDL, cardiometabolic state and gene expression: a nutrigenomic approach for cardiovascular prevention. J Cardiovasc Med (Hagerstown). 2019 Jul;20(7):419-426. doi: 10.2459/JCM.0000000000000816.

Reference Type DERIVED
PMID: 31593559 (View on PubMed)

Di Renzo L, Cioccoloni G, Falco S, Abenavoli L, Moia A, Sinibaldi Salimei P, De Lorenzo A. Influence of FTO rs9939609 and Mediterranean diet on body composition and weight loss: a randomized clinical trial. J Transl Med. 2018 Nov 12;16(1):308. doi: 10.1186/s12967-018-1680-7.

Reference Type DERIVED
PMID: 30419927 (View on PubMed)

Colica C, Avolio E, Bollero P, Costa de Miranda R, Ferraro S, Sinibaldi Salimei P, De Lorenzo A, Di Renzo L. Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety. Mediators Inflamm. 2017;2017:5650627. doi: 10.1155/2017/5650627. Epub 2017 Sep 24.

Reference Type DERIVED
PMID: 29147070 (View on PubMed)

Colica C, Di Renzo L, Trombetta D, Smeriglio A, Bernardini S, Cioccoloni G, Costa de Miranda R, Gualtieri P, Sinibaldi Salimei P, De Lorenzo A. Antioxidant Effects of a Hydroxytyrosol-Based Pharmaceutical Formulation on Body Composition, Metabolic State, and Gene Expression: A Randomized Double-Blinded, Placebo-Controlled Crossover Trial. Oxid Med Cell Longev. 2017;2017:2473495. doi: 10.1155/2017/2473495. Epub 2017 Aug 9.

Reference Type DERIVED
PMID: 28855976 (View on PubMed)

De Lorenzo A, Costacurta M, Merra G, Gualtieri P, Cioccoloni G, Marchetti M, Varvaras D, Docimo R, Di Renzo L. Can psychobiotics intake modulate psychological profile and body composition of women affected by normal weight obese syndrome and obesity? A double blind randomized clinical trial. J Transl Med. 2017 Jun 10;15(1):135. doi: 10.1186/s12967-017-1236-2.

Reference Type DERIVED
PMID: 28601084 (View on PubMed)

Colica C, Merra G, Gasbarrini A, De Lorenzo A, Cioccoloni G, Gualtieri P, Perrone MA, Bernardini S, Bernardo V, Di Renzo L, Marchetti M. Efficacy and safety of very-low-calorie ketogenic diet: a double blind randomized crossover study. Eur Rev Med Pharmacol Sci. 2017 May;21(9):2274-2289.

Reference Type DERIVED
PMID: 28537652 (View on PubMed)

Di Renzo L, Merra G, Botta R, Gualtieri P, Manzo A, Perrone MA, Mazza M, Cascapera S, De Lorenzo A. Post-prandial effects of hazelnut-enriched high fat meal on LDL oxidative status, oxidative and inflammatory gene expression of healthy subjects: a randomized trial. Eur Rev Med Pharmacol Sci. 2017 Apr;21(7):1610-1626.

Reference Type DERIVED
PMID: 28429343 (View on PubMed)

De Lorenzo A, Bernardini S, Gualtieri P, Cabibbo A, Perrone MA, Giambini I, Di Renzo L. Mediterranean meal versus Western meal effects on postprandial ox-LDL, oxidative and inflammatory gene expression in healthy subjects: a randomized controlled trial for nutrigenomic approach in cardiometabolic risk. Acta Diabetol. 2017 Feb;54(2):141-149. doi: 10.1007/s00592-016-0917-2. Epub 2016 Oct 5.

Reference Type DERIVED
PMID: 27709360 (View on PubMed)

Di Renzo L, Tyndall E, Gualtieri P, Carboni C, Valente R, Ciani AS, Tonini MG, De Lorenzo A. Association of body composition and eating behavior in the normal weight obese syndrome. Eat Weight Disord. 2016 Mar;21(1):99-106. doi: 10.1007/s40519-015-0215-y. Epub 2015 Sep 7.

Reference Type DERIVED
PMID: 26347355 (View on PubMed)

Di Renzo L, Marsella LT, Sarlo F, Soldati L, Gratteri S, Abenavoli L, De Lorenzo A. C677T gene polymorphism of MTHFR and metabolic syndrome: response to dietary intervention. J Transl Med. 2014 Nov 29;12:329. doi: 10.1186/s12967-014-0329-4.

Reference Type DERIVED
PMID: 25432492 (View on PubMed)

Di Renzo L, Carraro A, Valente R, Iacopino L, Colica C, De Lorenzo A. Intake of red wine in different meals modulates oxidized LDL level, oxidative and inflammatory gene expression in healthy people: a randomized crossover trial. Oxid Med Cell Longev. 2014;2014:681318. doi: 10.1155/2014/681318. Epub 2014 Apr 30.

Reference Type DERIVED
PMID: 24876915 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DM 06/12/2011 n° prot. 32064

Identifier Type: -

Identifier Source: org_study_id